ANIX Anixa Biosciences Inc
Company Analysis
Latest News
🟢 Anixa Biosciences is trading 11.05% up today
Anixa Biosciences is trading 11.05% higher at $3.09, with no confirmed catalyst for its October 23, 2026 move. - A report noted CEO Amit Kumar purchased 8,000...
🟢 Anixa Biosciences is trading 5.4% up today — no catalyst confirmed
Anixa Biosciences is trading up 5.4% at $2.93 as of 10:43 a.m. ET on October 23, 2026, with no clear catalyst identified. - The prior close was $2.78; no...
🟢 Anixa Biosciences is trading 6.1% up in pre-market amid reported CEO share purchase
Anixa Biosciences is trading 6.1% up in pre-market at $2.95 on October 23, 2026; CEO Amit Kumar’s reported purchase may be drawing attention, but its...
🟢 Anixa Biosciences is trading 5.5% up in after-hours trading
Anixa Biosciences is trading at $2.93, up 5.53% in after-hours trading; no confirmed company announcement explaining the move was found. - A report says CEO...
🟢 Anixa Biosciences is trading 5% up today amid biotech-sector gains; no specific catalyst identified
Anixa Biosciences is trading at $2.75, up 5.36%, with biotech-sector momentum offering a possible context for the move. - XBI was up 2.10% during regular...
🟢 Anixa Biosciences is trading 7% up in after-hours trading with no clear catalyst identified
Anixa Biosciences is trading at $2.84, up 6.97% after hours, with the rise unexplained pending further news. - The latest company announcement, on October 13,...
🟢 Anixa Biosciences is trading 8% up in pre-market
Anixa Biosciences is trading at $2.88, up 7.80% in pre-market, with no clear company-specific catalyst identified. - This compares with the October 13 close of...
🟢 Anixa Biosciences is trading 5% up in after-hours trading with no clear company-specific catalyst
Anixa Biosciences is trading 5.24% higher now at $2.81 after-hours, with no clear company-specific catalyst identified. - It closed at $2.67 on October 13,...
🔴 Anixa Biosciences is trading 5% down; no clear company-specific catalyst identified
Anixa Biosciences is trading 5.28% down at $2.69, with no clear company-specific catalyst identified. - On October 13, the company announced that its ovarian...
🔴 Anixa Biosciences is trading 7.6% down in pre-market with no direct catalyst identified
Anixa Biosciences is trading 7.6% lower at $2.68 in pre-market; no direct catalyst was identified. - The October 9 close was $2.90; supplied price context...
🟢 Anixa Biosciences is trading 6.2% up in pre-market; catalyst remains unclear
Anixa Biosciences is trading 6.19% up at $3.09 in pre-market on October 9, 2026, with no clear catalyst identified. - The October 8 close was $2.91; supplied...
Anixa Reports First 3-Month Stable Disease in Ovarian Cancer CAR-T Trial
Anixa Biosciences said the first patient treated in the fifth and highest-dose cohort of its Phase 1 trial for recurrent ovarian cancer has had stable disease...
🔴 Anixa Biosciences is trading 11.86% down in pre-market; cause remains unclear
Anixa Biosciences is trading 11.86% lower at $2.60, with the cause of the October 5 pre-market decline unclear. - Shares are down from the October 2 close of...
🟢 Anixa Biosciences is trading 5.6% up today amid gains across major indexes
Anixa Biosciences is trading 5.6% higher at $2.92, with broader market strength potentially supporting shares. - The S&P 500 is up 0.71%, the NASDAQ Composite...
🟢 Anixa Biosciences is trading 6.9% up in after-hours trading amid highest-dose ovarian cancer CAR-T cohort update
Anixa Biosciences is trading 6.91% higher after hours at $2.96; the trial update may be a catalyst, though no source directly linked it to the move. - Shares...
🔴 Anixa Biosciences is trading 5% down today
Anixa Biosciences is trading 5.12% down at $2.78, with no clear catalyst established. - On October 1, 2026, the company said a second patient had been treated...
🟢 Anixa Biosciences is trading 13% up in pre-market — catalyst remains unclear
Anixa Biosciences is trading at $3.31, up 13.06% in pre-market on October 1, with no clear catalyst identified. - This compares with the September 30 close of...
🔴 Anixa Biosciences is trading 5.38% down today after H.C. Wainwright cut its price target
Anixa Biosciences is trading 5.38% down at $2.64 after H.C. Wainwright lowered its price target to $6 from $7 while maintaining a Buy rating on September 23,...
🟢 Anixa Biosciences is trading 5.4% up in pre-market as biotech sector strengthens
Anixa Biosciences is trading 5.4% higher at $2.94 in pre-market, alongside broader biotechnology-sector strength. - XBI was up 2.61% pre-market. - No new...
🟢 Anixa Biosciences is trading 7.5% up in after-hours trading; catalyst remains unclear
Anixa Biosciences is trading up 7.5% at $3.00 after hours, with the catalyst unclear. - No new company-specific announcement, earnings release, or clearly...